AXA Framlington Biotech Fund Acc
Discount: 5.03%¹
Fund Overview |
|
|---|---|
| Unit Prices |
Buy: 60.72p
/ Sell: 57.37p
21/05/2012 |
| Standard Initial Charge | 5.50% |
| TQ Invest Discount | 5.03% |
| Initial Charge Through TQ Invest | 0.47% |
| Saving 2 | £567.38 |
| Annual Management Charge | 1.75% |
| Total Expense Ratio | 1.90% |
| Fund size | £67,400,000 |
| Usable in ISA | Yes |
Fund holding information
| Holding | Weighting |
|---|---|
| Icici Bank | 8.60% |
| Hogg Robinson Group Plc | 8.20% |
| Cantillon Funds Global Equity Fd - Cls A - Ser A1 | 7.60% |
| Neuberger Berman Investment Fds Plc Straus Us Equity Aud Adviser Acc | 6.40% |
| Housing Finance Corp 11.5% Deb Stk 2016 | 5.90% |
| Dixons Retail Plc 8.75% Mtn 03/08/15 Gbp1000 | 3.60% |
| Treasury 0% Tsy Bill 09/01/12 Gbp0.01 | 3.40% |
| Towergate Frn 04/08/17 Term Loan B | 2.50% |
| Upcb Finance Ii | 2.30% |
| Development Securities | 2.30% |
| Sector | Weighting |
|---|---|
| Biotechnology/Medical | 69.97% |
| Hardware | 13.90% |
| Distributors | 8.33% |
| Money Market | 3.36% |
| Telecom, Media & Technology | 1.94% |
| Health Care | 1.50% |
| Pharmaceuticals | 1.00% |
| Region | Weighting |
|---|---|
| North America | 89.89% |
| Europe Ex Uk | 3.89% |
| Money Market | 3.36% |
| Uk | 2.87% |
| Asset Type | Weighting |
|---|---|
| North American Equities | 89.89% |
| European Equities | 3.89% |
| Money Market | 3.36% |
| Uk Equities | 2.87% |
1Discount for an ISA investment through the Cofunds platform.
2Saving based on a typical ISA investment of £11,280.00 through the Cofunds platform.
Data provided by 
The value of this investment and the income from it can go down as well as up. Past performance should not be regarded as a guide to the future. The investment described may not be suitable for all recipients and this factsheet does not constitute personalised investment advice. No liability is accepted for any loss arising from errors or omissions.